Extracellular Matrix Patches Market To Reach $51.8 Million By 2030

Extracellular Matrix Patches Market Growth & Trends

The global extracellular matrix patches market size is expected to reach USD 51.8 million by 2030, registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular diseases, the rising number of trauma surgeries, and the growing adoption of ECM patches among healthcare providers are some of the key drivers for this market. Recent development of advanced ECM patches for soft tissue repair and wound healing procedures is also expected to positively impact market growth.

The surging number of hernia and pelvic restoration surgeries is also propelling demand for ECM patches in healing processes. Moreover, these patches offer greater biocompatibility, durability, and pliability than synthetic patches, which is expected to drive demand in the market. Favorable reimbursement support by governments around the world is also expected to boost the adoption and acceptance of these patches in the market.

The rising number of research activities for the development of extracellular matrix patches enables an expansion in applications, which in turn, drives the market. In addition, rising government initiatives toward improvement in healthcare infrastructure and increasing healthcare expenditure in developing countries are positively influencing the market growth. However, the high cost of these patches is a significant factor that can lower the adoption of these patches in lower- and middle- income countries.

 Request a free sample copy or view report summary: Extracellular Matrix Patches Market Report

Extracellular Matrix Patches Market Report Highlights

• ECM patches for soft tissue repair emerged as the largest application segment in terms of revenue in 2022, owing to the rising number of hernia repair and trauma surgeries·       

• ECM patches derived from porcine accounted for the largest revenue share in 2022 based on raw material owing to several benefits of porcine over other sources, such as reduction in scar formation, durability, and pliability

• In terms of geography, North America accounted for the largest revenue share in 2022 and Asia Pacific is expected to exhibit the fastest growth rate over the forecast period

Extracellular Matrix Patches Market Segmentation

Grand View Research has segmented the global extracellular matrix patches market on the basis of application, raw material, and region:

Extracellular Matrix Patches Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac Repair

• Vascular Repair & Reconstruction

• Pericardial Repair

• Dural Repair

• Soft Tissue Repair

• Wound Healing

Extracellular Matrix Patches Raw Material Outlook (Revenue, USD Million, 2018 - 2030)

• Bovine

• Porcine

• Others

Extracellular Matrix Patches Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Extracellular Matrix Patches Market 

• Cook Group

• Coloplast Group

• Smith & Nephew

• Koninklijke DSM N.V.

• MTF Biologics

• Boston Scientific Corporation

• Medtronic

• Baxter

• Aziyo Biologics

• Admedus Ltd.